Frederic E. Van Heuverswyn, M.D; Liesbeth Timmers, M.D; Roland X. Stroobandt, M.D., Ph.D; S. Serge Barold, M.D ...

Over the past decades, hypertrophic cardiomyopathy has become a contemporary treatable disease. However, limited data exist on the global trends of implantable cardioverter defibrillator (ICD) ...

YOU ARE HERE: Home > Guidelines > Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing: Appropriate Use Criteria ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

"I had a subcutaneous implantable cardioverter defibrillator fitted on May 2 and was released from hospital the same day." Mr Griffiths, who is a One Stop manager, returned to work just 10 days ...

ACC's EP Device Implant Registry is a critical tool for tracking and improving outcomes for patients receiving ICD/CRT-D and pacemaker procedures. The newly launched Version 3.0 has streamlined ...

Registering your defibrillator on The Circuit ensures that ambulance services can locate your defibrillator and direct people to it in an emergency. When someone has a cardiac arrest, every minute ...

The FDA approved subcutaneous Opdivo for solid tumors, providing a more convenient treatment option that reduces time toxicity and enhances patient accessibility. Subcutaneous administration allows ...